Clinical trial
Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer
NCT00033904 · Agenus Inc., Industry · Completed
Key facts
| NCT number | NCT00033904 |
|---|---|
| Title | Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer |
| Official title | A Multi-Center, Randomized Phase III Study of Adjuvant Oncophage® Versus Observation in Subjects With High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma |
| Lead sponsor | Agenus Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Renal Cell Carcinoma |
| Intervention type | Drug |
| Interventions | autologous human tumor-derived HSPPC-96 |
| Enrollment | 650 |
| Start date | Jun 1, 2000 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Apr 15, 2002 |
| Last update posted | Sep 7, 2012 |
| Countries | Austria, Belgium, Canada, France, Israel, Norway, Poland, Spain, Sweden, United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: